相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。OPERA: responses to peginterferon and ribavirin therapy in a subgroup of interferon-naive patients with HIV/HCV genotype 2/3 co-infection in Italy
Raffaele Bruno et al.
LIVER INTERNATIONAL (2015)
Discrimination by health care workers versus discrimination by others: Countervailing forces on HCV treatment intentions
Loren Brener et al.
PSYCHOLOGY HEALTH & MEDICINE (2015)
Asunaprevir-containing regimens for the treatment of hepatitis C virus infection
Sheng-Shun Yang et al.
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY (2015)
Patients' preferences and health utility assessment with SF-6D and EQ-5D in patients with chronic hepatitis C treated with sofosbuvir regimens
M. Stepanova et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
The impact of hepatitis C burden: an evidence-based approach
Z. M. Younossi et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2014)
Multiple Factors Predict Physical Performance in People with Chronic Liver Disease
Anthony Loria et al.
AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION (2014)
Fatigue during treatment for hepatitis C virus: results of self-reported fatigue severity in two Phase IIb studies of simeprevir treatment in patients with hepatitis C virus genotype 1 infection
Jane Scott et al.
BMC INFECTIOUS DISEASES (2014)
Effects of Sofosbuvir-Based Treatment, With and Without Interferon, on Outcome and Productivity of Patients With Chronic Hepatitis C
Zobair M. Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Similar Effectiveness of Boceprevir and Telaprevir Treatment Regimens for Hepatitis C Virus Infection on the Basis of a Nationwide Study of Veterans
George N. Ioannou et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials
Jean B. Nachega et al.
CLINICAL INFECTIOUS DISEASES (2014)
Effectiveness of Telaprevir and Boceprevir Triple Therapy for Patients with Hepatitis C Virus Infection in a Large Integrated Care Setting
Jennifer C. Price et al.
DIGESTIVE DISEASES AND SCIENCES (2014)
Treatment for chronic hepatitis C in a cohort of opiate substitution therapy recipients in three Swedish cities - completion rates and efficacy
Anna Jerkeman et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2014)
Simeprevir With Peginterferon and Ribavirin Leads to High Rates of SVR in Patients With HCV Genotype 1 Who Relapsed After Previous Therapy: A Phase 3 Trial
Xavier Forns et al.
GASTROENTEROLOGY (2014)
Patient-Reported Outcomes in Chronic Hepatitis C Patients With Cirrhosis Treated With Sofosbuvir-Containing Regimens
Zobair M. Younossi et al.
HEPATOLOGY (2014)
Citalopram for the Prevention of Depression and Its Consequences in HIV-Hepatitis C Coinfected Individuals Initiating Pegylated Interferon/Ribavirin Therapy: A Multicenter Randomized Double-Blind Placebo-Controlled Trial
Marina B. Klein et al.
HIV CLINICAL TRIALS (2014)
Hepatitis C and Work Impairment A Review of Current Literature
Vignan Manne et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2014)
Longitudinal Effects of Selective Serotonin Reuptake Inhibitor Therapy and Cytokine-Related Depression on Hepatitis C Viral Logs During Antiviral Therapy
Omar T. Sims et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Minimal impact of sofosbuvir and ribavirin on health related quality of life in Chronic Hepatitis C (CH-C)
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Patient-reported outcomes assessment in chronic hepatitis C treated with sofosbuvir and ribavirin: The VALENCE study
Zobair M. Younossi et al.
JOURNAL OF HEPATOLOGY (2014)
Worker Productivity Outcome Measures: OMERACT Filter Evidence and Agenda for Future Research
Kenneth Tang et al.
JOURNAL OF RHEUMATOLOGY (2014)
Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial
Ira M. Jacobson et al.
LANCET (2014)
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection
Nezam Afdhal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Stefan Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis
Kris V. Kowdley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Predictive Factors for Sustained Virological Response after Treatment with Pegylated Interferon α-2a and Ribavirin in Patients Infected with HCV Genotypes 2 and 3
Claus Niederau et al.
PLOS ONE (2014)
Psychometric evaluation of the hepatitis C virus patient-reported outcomes (HCV-PRO) instrument: validity, responsiveness, and identification of the minimally important difference in a phase 2 clinical trial
Roger T. Anderson et al.
QUALITY OF LIFE RESEARCH (2014)
Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself
Edna Strauss et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2014)
The Risk of Long-term Morbidity and Mortality in Patients With Chronic Hepatitis C Results From an Analysis of Data From a Department of Veterans Affairs Clinical Registry
Jeffrey McCombs et al.
JAMA INTERNAL MEDICINE (2014)
Hepatitis C treatment and SVR: the gap between clinical trials and real-world treatment aspirations
Carol S. North et al.
GENERAL HOSPITAL PSYCHIATRY (2013)
The effect of liver transplantation on fatigue in patients with primary biliary cirrhosis: A prospective study
Marco Carbone et al.
JOURNAL OF HEPATOLOGY (2013)
Sofosbuvir: the final nail in the coffin for hepatitis C?
Michael P. Manns et al.
LANCET INFECTIOUS DISEASES (2013)
Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
Ira M. Jacobson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Exploratory Study of Oral Combination Antiviral Therapy for Hepatitis C
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
Eric Lawitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Eligibility and Safety of Triple Therapy for Hepatitis C: Lessons Learned from the First Experience in a Real World Setting
Benjamin Maasoumy et al.
PLOS ONE (2013)
Prevalence of minimal hepatic encephalopathy and quality of life evaluations in hospitalized cirrhotic patients in China
Ji-Yao Wang et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2013)
Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review
Viktor Mravcik et al.
PATIENT PREFERENCE AND ADHERENCE (2013)
The Hepatitis C Self-Management Program: Sustainability of Primary Outcomes at 1 Year
Erik J. Groessl et al.
HEALTH EDUCATION & BEHAVIOR (2013)
Escitalopram for the Prevention of Peginterferon-α2a-Associated Depression in Hepatitis C Virus-Infected Patients Without Previous Psychiatric Disease A Randomized Trial
Martin Schaefer et al.
ANNALS OF INTERNAL MEDICINE (2012)
The Burden of Untreated Hepatitis C Virus Infection: A US Patients' Perspective
Antoine C. El Khoury et al.
DIGESTIVE DISEASES AND SCIENCES (2012)
The burden of viral hepatitis C in Europe: a propensity analysis of patient outcomes
Marco daCosta DiBonaventura et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2012)
Health utilities and psychometric quality of life in patients with early- and late-stage hepatitis C virus infection
Priscilla C. Hsu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2012)
Factors related to quality of life in patients with cirrhosis and ascites: Relevance of serum sodium concentration and leg edema
Elsa Sola et al.
JOURNAL OF HEPATOLOGY (2012)
Barriers to hepatitis C treatment
Christopher E. McGowan et al.
LIVER INTERNATIONAL (2012)
The Burden of Illness for Patients with Viral Hepatitis C: Evidence from a National Survey in Japan
Gordon G. Liu et al.
VALUE IN HEALTH (2012)
Randomised clinical trial: rifaximin improves health-related quality of life in cirrhotic patients with hepatic encephalopathy - a double-blind placebo-controlled study
A. Sanyal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
The Results of Phase III Clinical Trials With Telaprevir and Boceprevir Presented at the Liver Meeting 2010: A New Standard of Care for Hepatitis C Virus Genotype 1 Infection, But With Issues Still Pending
Jean–Michel Pawlotsky
GASTROENTEROLOGY (2011)
Insurance Status and Treatment Candidacy of Hepatitis C Patients: Analysis of Population-Based Data from the United States
Maria Stepanova et al.
HEPATOLOGY (2011)
Previous overt hepatic encephalopathy rather than minimal hepatic encephalopathy impairs health-related quality of life in cirrhotic patients
Federica Moscucci et al.
LIVER INTERNATIONAL (2011)
Boceprevir for Untreated Chronic HCV Genotype 1 Infection
Fred Poordad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The impact of hepatitis C on labor force participation, absenteeism, presenteeism and non-work activities
Marco daCosta DiBonaventura et al.
JOURNAL OF MEDICAL ECONOMICS (2011)
Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis
Luis Company et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Quality of life in cirrhosis is related to potentially treatable factors
Inigo Les et al.
EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2010)
Evaluation of Medication Adherence and Quality of Life in Patients With Hepatitis C Virus Receiving Combination Therapy
Jennifer L. Rodis et al.
GASTROENTEROLOGY NURSING (2010)
Using qualitative methods to inform the trade-off between content validity and consistency in utility assessment: the example of type 2 diabetes and Alzheimer's Disease
Clare Mcgrath et al.
HEALTH AND QUALITY OF LIFE OUTCOMES (2010)
The Impact of Hepatitis C Virus Infection on Work Absence, Productivity, and Healthcare Benefit Costs
Jun Su et al.
HEPATOLOGY (2010)
Psychological Determinants of Health-Related Quality of Life in Patients With Chronic Liver Disease
J. J. Gutteling et al.
PSYCHOSOMATICS (2010)
A Methodology for Successfully Producing Global Translations of Patient Reported Outcome Measures for Use in Multiple Countries
Rebecca Two et al.
VALUE IN HEALTH (2010)
Predictors of health-related quality of life in patients with chronic liver disease
A. Afendy et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2009)
Sustained Responders Have Better Quality of Life and Productivity Compared With Treatment Failures Long After Antiviral Therapy for Hepatitis C
Ava A. John-Baptiste et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2009)
Health-Related Quality of Life Predicts Mortality in Patients With Advanced Chronic Liver Disease
Fasiha Kanwal et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Psychiatric Problems in Patients Infected with Hepatitis C Before and During Antiviral Treatment with Interferon-Alpha: A Review
Rosa Quelras et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2009)
Management of chronic hepatitis C in veterans: The potential of integrated care models
Samuel B. Ho et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
Impact of chronic liver disease and cirrhosis on health utilities using SF-6D and the health utility index
Amy A. Dan et al.
LIVER TRANSPLANTATION (2008)
Pegylated interferon alfa and ribavirin for 14 versus 24 weeks in patients with hepatitis C virus genotype 2 or 3 and rapid virological response
Olav Dalgard et al.
HEPATOLOGY (2008)
Fatigue and health-related quality of life (HRQL) in chronic hepatitis C virus infection
Jillian Kallman et al.
DIGESTIVE DISEASES AND SCIENCES (2007)
Anger experiences among hepatitis C patients: Relationship to depressive symptoms and health-related quality of life
Amy A. Dan et al.
PSYCHOSOMATICS (2007)
Generic and disease-specific health related quality of life of liver patients with various aetiologies: A survey
Simone M. van der Plas et al.
QUALITY OF LIFE RESEARCH (2007)
Health-related quality of life in patients with chronic hepatitis C and advanced fibrosis
Herbert L. Bonkovsky et al.
JOURNAL OF HEPATOLOGY (2007)
Health-related quality of life of chronic liver disease patients with and without hepatocellular carcinoma
Yuji Kondo et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2007)
The effects of HCV infection and management on health-related quality of life
Zobair Younossi et al.
HEPATOLOGY (2007)
Factors influencing health-related quality of life in chronic liver disease
Abhasnee Sobhonslidsuk et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2006)
Determinants of quality of life in chronic liver patients
J. . J. . Gutteling et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
Social stigmatization and hepatitis C virus infection
S Zacks et al.
JOURNAL OF CLINICAL GASTROENTEROLOGY (2006)
Health-related quality of life (HRQL) in chronic liver disease
LM Martin et al.
DIGESTIVE AND LIVER DISEASE (2005)
Impact of hepatitis C on health related quality of life: A systematic review and quantitative assessment
BMR Spiegel et al.
HEPATOLOGY (2005)
The effect of adherence to therapy on sustained response in daily or three times a week interferon alpha-2b plus ribavirin treatment of naive and nonresponder chronic hepatitis C patients
M Raptopoulou et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Reasons for non-treatment of hepatitis C in veterans in care
AA Butt et al.
JOURNAL OF VIRAL HEPATITIS (2005)
Hepatitis C virus-infected patients report communication problems with physicians
S Zickmund et al.
HEPATOLOGY (2004)
The impact of peginterferon alfa-2a plus ribavirin combination therapy on health-related quality of life in chronic hepatitis C
T Hassanein et al.
JOURNAL OF HEPATOLOGY (2004)
Comparison of quality of life, work productivity and medical resource utilization of peginterferon alpha 2a vs the combination of interferon alpha 2b plus ribavirin as initial treatment in patients with chronic hepatitis C
R Perrillo et al.
JOURNAL OF VIRAL HEPATITIS (2004)
Determinants of Health-Related Quality of Life in Patients With Chronic Liver Diseases
Winfried Haeuser et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
The Liver Disease Symptom Index 2.0; Validation of a disease-specific questionnaire
SM van der Plas et al.
QUALITY OF LIFE RESEARCH (2004)
Effectiveness of Interferon α-2b and Ribavirin Combination Therapy in the Treatment of Naive Chronic Hepatitis C Patients in Clinical Practice
Thomas M. Shehab et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2004)
Early virologic response to treatment with peginterferon alfa-2b plus ribavirin in patients with chronic hepatitis C
GL Davis et al.
HEPATOLOGY (2003)
Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis
MR Arguedas et al.
DIGESTIVE DISEASES AND SCIENCES (2003)
An empirical comparison of EQ-5D and SF-6D in liver transplant patients
L Longworth et al.
HEALTH ECONOMICS (2003)
Adherence to combination therapy enhances sustained response in genotyp-1-infected patients with chronic hepatitis C
JG McHutchison et al.
GASTROENTEROLOGY (2002)
Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998
P Ferenci et al.
HEPATOLOGY (2002)
Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients
D Bernstein et al.
HEPATOLOGY (2002)
The estimation of a preference-based measure of health from the SF-36
J Brazier et al.
JOURNAL OF HEALTH ECONOMICS (2002)
The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity
JG McHutchison et al.
JOURNAL OF HEPATOLOGY (2001)
Factors associated with poor health-related quality of life of patients with cirrhosis
G Marchesini et al.
GASTROENTEROLOGY (2001)
Interpreting SF-36 summary health measures: A response
JE Ware et al.
QUALITY OF LIFE RESEARCH (2001)
分享论文
